PEGASYS Side Effects

7022469-9 | Vogt-koyanagi-harada Syndrome
on Sep 22, 2010 Female patient from SWITZERLAND , 45 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: vogt-koyanagi-harada syndrome. Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ).

7022407-9 | Back Pain, Blood Pressure Increased, Fatigue, Headache, Insomnia, Myalgia, Nephrolithiasis, Pain In Extremity
Patient was taking Pegasys (View Usage). Patient had the following side effects: back pain (What is back pain?), blood pressure increased, fatigue, headache (What is headache?), insomnia, myalgia, nephrolithiasis, pain in extremity on Sep 25, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 140.0 lb, was diagnosed with hepatitis c (What is hepatitis c?), white blood cell count decreased and. Pegasys dosage: Form: Pre Filled Syringes. During the same period patient was treated with COPEGUS (Daily Divided Doses) (View Copegus Review and Copegus Label ), NEUPOGEN (Received Four Injections) (View Neupogen Review and Neupogen Label ).

7018133-2 | Dermatitis, Dyspnoea, Procedural Complication, Pulmonary Oedema
Adverse event was reported on Sep 20, 2010 by a Female patient taking Pegasys (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , weighting 192.9 lb, After Pegasys was administered, patient had the following side effects: dermatitis, dyspnoea, procedural complication, pulmonary oedema. During the same period patient was treated with RIBASPHERE (View Ribasphere Review and Ribasphere Label ), BENICAR (View Benicar Review and Benicar Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

7014746-2 | Bone Marrow Failure, Cardiac Failure Congestive, Nephrotic Syndrome, Renal Failure Acute
on Sep 14, 2010 Female patient from JAPAN , 73 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: bone marrow failure, cardiac failure congestive, nephrotic syndrome, renal failure acute. Pegasys dosage: . During the same period patient was treated with REBETOL (Note: Dosage Is Uncertain.) (View Rebetol Review and Rebetol Label ). Patient was hospitalized.


7014717-6 | Focal Segmental Glomerulosclerosis
on Sep 15, 2010 Female patient from JAPAN , 68 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient had the following side effects: focal segmental glomerulosclerosis. Pegasys dosage: Dosage Is Uncertain.. During the same period patient was treated with COPEGUS (Dosage Is Uncertain.) (View Copegus Review and Copegus Label ).

7014658-4 | Erysipelas, Granulocytopenia, Oesophageal Varices Haemorrhage, Septic Shock
Patient was taking Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: erysipelas, granulocytopenia, oesophageal varices haemorrhage, septic shock on Sep 17, 2010 from TUNISIA Additional patient health information: Female patient , weighting 242.5 lb, . Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ).

7014641-9 | Eczema, Gastritis, Hypertension, Vitreous Haemorrhage
Adverse event was reported on Sep 16, 2010 by a Male patient taking Pegasys (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: JAPAN , weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: eczema (What is eczema?), gastritis, hypertension, vitreous haemorrhage. During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ).

7013337-7 | Hypoproteinaemia, Pericardial Effusion
on Sep 15, 2010 Female patient from JAPAN , 63 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient had the following side effects: hypoproteinaemia, pericardial effusion. Pegasys dosage: . Patient was hospitalized.

7012661-1 | Ataxia, Dysarthria, Dyskinesia, Head Titubation, Paraesthesia Oral
on Sep 14, 2010 Female patient from UNITED STATES , weighting 175.9 lb, was diagnosed with hepatitis c (What is hepatitis c?), osteoarthritis (What is osteoarthritis?), somnolence, pain (What is pain?) and was treated with Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: ataxia (What is ataxia?), dysarthria, dyskinesia, head titubation, paraesthesia oral. Pegasys dosage: . During the same period patient was treated with RIBAVIRIN (View Ribavirin Review and Ribavirin Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), TRAZODONE HCL (Every Morning) (View Trazodone Hcl Review and Trazodone Hcl Label ), CALCIUM/VITAMIN D (View Calcium/vitamin D Review and Calcium/vitamin D Label ), VICODIN (Hydrocodone/paracetamol: 500/10 Mg) (View Vicodin Review and Vicodin Label ).

7009851-0 | Nephrotic Syndrome
Patient was taking Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: nephrotic syndrome on Sep 15, 2010 from JAPAN Additional patient health information: Female patient , 68 years of age, . Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ). Patient was hospitalized.

7007845-2 | Hypoproteinaemia, Pericardial Effusion
Adverse event was reported on Sep 15, 2010 by a Female patient taking Pegasys (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: JAPAN , 63 years of age, Patient had the following side effects: hypoproteinaemia, pericardial effusion. Patient was hospitalized.

7007816-6 | Ataxia, Dysarthria, Dyskinesia, Head Titubation, Paraesthesia Oral
on Sep 14, 2010 Female patient from UNITED STATES , weighting 175.9 lb, was diagnosed with hepatitis c (What is hepatitis c?), osteoarthritis (What is osteoarthritis?), somnolence, pain (What is pain?) and was treated with Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: ataxia (What is ataxia?), dysarthria, dyskinesia, head titubation, paraesthesia oral. Pegasys dosage: . During the same period patient was treated with RIBAVIRIN (View Ribavirin Review and Ribavirin Label ), ALENDRONATE SODIUM (View Alendronate Sodium Review and Alendronate Sodium Label ), TRAZODONE HCL (Every Morning) (View Trazodone Hcl Review and Trazodone Hcl Label ), CALCIUM/VITAMIN D (View Calcium/vitamin D Review and Calcium/vitamin D Label ), VICODIN (Hydrocodone/paracetamol: 500/10 Mg) (View Vicodin Review and Vicodin Label ).

7007783-5 | Convulsion
on Sep 15, 2010 Male patient from UNITED STATES , 55 years of age, weighting 190.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

7001266-4 | Anaemia, Asthenia, Hypoalbuminaemia, Pancytopenia, Septic Shock
Patient was taking Pegasys (View Usage). Patient had the following side effects: anaemia, asthenia, hypoalbuminaemia, pancytopenia, septic shock on Sep 06, 2010 from ISRAEL Additional patient health information: Male patient , 54 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ).

7001135-X | Hemiparesis, Platelet Count Decreased, Thalamus Haemorrhage
Adverse event was reported on Sep 07, 2010 by a Male patient taking Pegasys (View Usage) (Dosage: ) . Location: JAPAN , weighting 123.5 lb, After Pegasys was administered, patient had the following side effects: hemiparesis, platelet count decreased, thalamus haemorrhage. During the same period patient was treated with URSODESOXYCHOLIC ACID (View Ursodesoxycholic Acid Review and Ursodesoxycholic Acid Label ), NORVASC (Note: 2007/9/3 Former) (View Norvasc Review and Norvasc Label ), NOVORAPID (Note: Morning Before 2007/9/3) (View Novorapid Review and Novorapid Label ).

6992579-0 | Chills, Depression, Irritability, Pain, Paranoia
on Sep 07, 2010 Female patient from UNITED STATES , weighting 162.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: chills, depression (What is depression?), irritability, pain (What is pain?), paranoia. Pegasys dosage: . During the same period patient was treated with RIBAVARIN (Divided Doses) (View Ribavarin Review and Ribavarin Label ).

6992551-0 | Asthenia, Diarrhoea, Dyspnoea, Faecal Incontinence, Hypoacusis, Movement Disorder, Speech Disorder, Tunnel Vision, Vertigo
on Sep 09, 2010 Female patient from UNITED STATES , weighting 242.1 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient had the following side effects: asthenia, diarrhoea, dyspnoea, faecal incontinence, hypoacusis, movement disorder (What is movement disorder?), speech disorder, tunnel vision, vertigo. Pegasys dosage: Frequency Reported As: X1.. During the same period patient was treated with ACIPHEX (View Aciphex Review and Aciphex Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

6973244-2 | Cataplexy, Disturbance In Attention, Hypersomnia, Memory Impairment, Road Traffic Accident
Patient was taking Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: cataplexy, disturbance in attention, hypersomnia, memory impairment, road traffic accident on Sep 01, 2010 from FRANCE Additional patient health information: Male patient , 45 years of age, was diagnosed with hepatitis c (What is hepatitis c?), depression (What is depression?) and. Pegasys dosage: Other Indication: Post-hepatic Cirrhosis. During the same period patient was treated with KALETRA (View Kaletra Review and Kaletra Label ), TRANXENE (View Tranxene Review and Tranxene Label ), EFFEXOR (View Effexor Review and Effexor Label ), LEXOMIL (View Lexomil Review and Lexomil Label ).

6973187-4 | Hepatic Mass
Adverse event was reported on Aug 30, 2010 by a Female patient taking Pegasys (View Usage) (Dosage: ) . Location: UNITED STATES , 59 years of age, Patient experienced the following unwanted or unexpected effects: hepatic mass. During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ).

6973181-3 | Erysipelas, Granulocytopenia, Septic Shock
on Sep 01, 2010 Female patient from TUNISIA , weighting 242.5 lb, was treated with Pegasys (View Usage). Patient had the following side effects: erysipelas, granulocytopenia, septic shock. Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ).

6970443-0 | Anaemia, Anti-erythropoietin Antibody Positive
on Sep 16, 2009 Female patient from FRANCE , 49 years of age, was diagnosed with hepatitis c (What is hepatitis c?), anaemia, depression (What is depression?) and was treated with Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: anaemia, anti-erythropoietin antibody positive. Pegasys dosage: Form: Injection. During the same period patient was treated with NEORECORMON (Form: Injection) (View Neorecormon Review and Neorecormon Label ), COPEGUS (Dose Reduced) (View Copegus Review and Copegus Label ), NOCTRAN (View Noctran Review and Noctran Label ), SUBUTEX (View Subutex Review and Subutex Label ). Patient was hospitalized.

6970439-9 | Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Face Oedema
Patient was taking Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, face oedema on Aug 27, 2010 from JAPAN Additional patient health information: Female patient , 71 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and. Pegasys dosage: Uncertainity. During the same period patient was treated with RIBAVIRIN (View Ribavirin Review and Ribavirin Label ).

6968292-2 | Viith Nerve Paralysis
Adverse event was reported on Aug 30, 2010 by a Male patient taking Pegasys (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: FRANCE , weighting 147.7 lb, Patient had the following side effects: viith nerve paralysis. During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ).

6966358-4 | Vitreous Haemorrhage
on Aug 25, 2010 Male patient from JAPAN , 53 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: vitreous haemorrhage. Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ).

6965683-0 | Lacunar Infarction
on Aug 26, 2010 Male patient from JAPAN , weighting 172.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: lacunar infarction. Pegasys dosage: . During the same period patient was treated with GLYBURIDE (View Glyburide Review and Glyburide Label ). Patient was hospitalized.

6965641-6 | Abdominal Pain, Arthralgia, Chest Discomfort, Nausea, Pyrexia, Red Blood Cell Count Abnormal, Splenomegaly, Thrombocytopenia
Patient was taking Pegasys (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), arthralgia, chest discomfort, nausea (What is nausea?), pyrexia, red blood cell count abnormal, splenomegaly, thrombocytopenia on Aug 26, 2010 from JAPAN Additional patient health information: Female patient , weighting 90.39 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ), ANYRUME (View Anyrume Review and Anyrume Label ).

6965578-2 | Hypokalaemia
Adverse event was reported on Aug 27, 2010 by a Female patient taking Pegasys (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: JAPAN , 80 years of age, weighting 81.57 lb, After Pegasys was administered, patient had the following side effects: hypokalaemia. Patient was hospitalized.

6962988-4 | Hepatic Cirrhosis
on Aug 28, 2010 Male patient from IRAN (ISLAMIC REPUBLIC OF) , 45 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic cirrhosis. Pegasys dosage: .

6960770-5 | Autoimmune Hepatitis, Cytomegalovirus Infection, Diabetes Mellitus, Hypoproteinaemia, Pneumocystis Jiroveci Pneumonia, Proteinuria, Renal Failure
on Aug 18, 2010 Male patient from JAPAN , 51 years of age, was diagnosed with hepatitis c (What is hepatitis c?), cytomegalovirus infection (What is cytomegalovirus infection?), liver transplant (What is liver transplant?) and was treated with Pegasys (View Usage). Patient had the following side effects: autoimmune hepatitis, cytomegalovirus infection (What is cytomegalovirus infection?), diabetes mellitus, hypoproteinaemia, pneumocystis jiroveci pneumonia, proteinuria, renal failure. Pegasys dosage: Note: Dosage Is Uncertain.. During the same period patient was treated with COPEGUS (Note: Dosage Is Uncertain.) (View Copegus Review and Copegus Label ), PEG INTRON (Note: 0.5ug/kg) (View Peg-intron Review and Peg-intron Label ), PEG INTRON (Note: 0.5ug/kg) (View Peg-intron Review and Peg-intron Label ), DENOSINE (View Denosine Review and Denosine Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), ADRENOCORTICAL HORMONE NOS (View Adrenocortical Hormone Nos Review and Adrenocortical Hormone Nos Label ).

6960710-9 | Allergic Granulomatous Angiitis, Infection
Patient was taking Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: allergic granulomatous angiitis, infection (What is infection?) on Aug 26, 2010 from GREENLAND Additional patient health information: Male patient , 48 years of age, weighting 136.7 lb, . Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ). Patient was hospitalized.

6960670-0 | Abdominal Pain Upper, Anaemia, Chills, Depression, Diarrhoea, Dizziness, Dyspnoea, Faeces Discoloured, Fatigue
Adverse event was reported on Aug 25, 2010 by a Female patient taking Pegasys (View Usage) (Dosage: Pre-filled Syringe) was diagnosed with hepatitis c (What is hepatitis c?), arthritis (What is arthritis?), hypertension and. Location: UNITED STATES , weighting 130.1 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, anaemia, chills, depression (What is depression?), diarrhoea, dizziness (What is dizziness?), dyspnoea, faeces discoloured, fatigue. During the same period patient was treated with RIBASPHERE (Dose: 600/400) (View Ribasphere Review and Ribasphere Label ), MELOXICAM (View Meloxicam Review and Meloxicam Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), PROTONIX (View Protonix Review and Protonix Label ).

6958571-7 | Convulsion
on Aug 24, 2010 Male patient from UNITED STATES , 50 years of age, was treated with Pegasys (View Usage). Patient had the following side effects: convulsion. Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ).

6958558-4 | Convulsion
on Aug 25, 2010 Male patient from UNITED STATES , 54 years of age, weighting 190.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: convulsion. Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ), DIAZEPAM (View Diazepam Review and Diazepam Label ).

6958444-X | Optic Ischaemic Neuropathy
Patient was taking Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: optic ischaemic neuropathy on Aug 25, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 140.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Pegasys dosage: . During the same period patient was treated with RIBAVIRIN (View Ribavirin Review and Ribavirin Label ).

6958439-6 | Diabetes Mellitus, Diabetic Ketoacidosis, Nausea, Pancreatitis Acute
Adverse event was reported on Aug 23, 2010 by a Male patient taking Pegasys (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , weighting 190.0 lb, Patient had the following side effects: diabetes mellitus, diabetic ketoacidosis, nausea (What is nausea?), pancreatitis acute. During the same period patient was treated with RIBAVIRIN (View Ribavirin Review and Ribavirin Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), ZOCOR (View Zocor Review and Zocor Label ). Patient was hospitalized.

6955857-7 | Abdominal Pain, Pyrexia, Splenomegaly, Thrombocytopenia
on Aug 26, 2010 Female patient from JAPAN , weighting 90.39 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), pyrexia, splenomegaly, thrombocytopenia. Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ).

6955754-7 | Aggression, Anxiety, Bipolar Disorder, Insomnia, Post-traumatic Stress Disorder, Psychotic Disorder
on Aug 23, 2010 Male patient from UNITED STATES , weighting 218.0 lb, was diagnosed with hepatitis c (What is hepatitis c?), depression (What is depression?), anxiety (What is anxiety?) and was treated with Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: aggression, anxiety (What is anxiety?), bipolar disorder (What is bipolar disorder?), insomnia, post-traumatic stress disorder (What is post-traumatic stress disorder?), psychotic disorder (What is psychotic disorder?). Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ), WELLBUTRIN (View Wellbutrin Review and Wellbutrin Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), AMBIEN (Other Indication: Sleep) (View Ambien Review and Ambien Label ). Patient was hospitalized.

6945513-3 |
Patient was taking Pegasys (View Usage). on Aug 18, 2010 from GERMANY Additional patient health information: Female patient , weighting 178.6 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ).

6945459-0 | Asthenia, Constipation, Diarrhoea, Insomnia, Nausea, Pyrexia
Adverse event was reported on Aug 19, 2010 by a Female patient taking Pegasys (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: VENEZUELA , weighting 108.0 lb, After Pegasys was administered, patient had the following side effects: asthenia, constipation (What is constipation?), diarrhoea, insomnia, nausea (What is nausea?), pyrexia. During the same period patient was treated with RIBAVIRIN (View Ribavirin Review and Ribavirin Label ).

6942916-8 | Inappropriate Antidiuretic Hormone Secretion
on Aug 18, 2010 Male patient from JAPAN , 62 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: inappropriate antidiuretic hormone secretion. Pegasys dosage: Dosage Is Uncertain.. During the same period patient was treated with COPEGUS (Dosage Is Uncertain.) (View Copegus Review and Copegus Label ). Patient was hospitalized.

6940711-7 | Abdominal Pain, Pyrexia, Splenomegaly, Thrombocytopenia
on Aug 16, 2010 Female patient from JAPAN , weighting 90.39 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), pyrexia, splenomegaly, thrombocytopenia. Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ).

6937737-6 | Hospitalisation
Patient was taking Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: hospitalisation on Aug 20, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 241.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Pegasys dosage: 180mcg -0.5ml Weekly Sq. During the same period patient was treated with RIBASPHERE (200 Mg Twice Daily Sq) (View Ribasphere Review and Ribasphere Label ). Patient was hospitalized.

6937481-5 | Pain In Extremity, Skin Lesion
Adverse event was reported on Aug 23, 2010 by a Male patient taking Pegasys (View Usage) (Dosage: 180 Mcg -0.5 Ml- Every Week Sq) was diagnosed with hepatitis c (What is hepatitis c?) and. Location: UNITED STATES , 58 years of age, weighting 200.0 lb, Patient experienced the following unwanted or unexpected effects: pain in extremity, skin lesion.

6937462-1 | Dysphagia, Gastrointestinal Haemorrhage, Salmonellosis, Walking Disability
on Aug 12, 2010 Female patient from TAIWAN, PROVINCE OF CHINA , 66 years of age, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient had the following side effects: dysphagia, gastrointestinal haemorrhage, salmonellosis, walking disability. Pegasys dosage: . During the same period patient was treated with RIBAVIRIN (Frequency: Daily.) (View Ribavirin Review and Ribavirin Label ). Patient was hospitalized.

6933937-X | Cardiomyopathy
on Aug 16, 2010 Female patient from JAPAN , 60 years of age, was treated with Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: cardiomyopathy (What is cardiomyopathy?). Pegasys dosage: . Patient was hospitalized.

6933906-X | Chest Pain, Fatigue, Hyperthyroidism, Impaired Work Ability, Influenza Like Illness, Sinus Tachycardia
Patient was taking Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), fatigue, hyperthyroidism, impaired work ability, influenza like illness, sinus tachycardia on Aug 13, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 171.1 lb, was diagnosed with hepatitis c (What is hepatitis c?) and. Pegasys dosage: . During the same period patient was treated with RIBAVIRIN (View Ribavirin Review and Ribavirin Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), RESTORIL (Taken As Needed) (View Restoril Review and Restoril Label ), REMERON (Taken Every Night At Bedtime) (View Remeron Review and Remeron Label ).

6933873-9 | Diabetic Ketoacidosis, Hypocalcaemia, Hypophosphataemia, Impaired Healing, Pancreatitis Acute, Surgery, Thrombocytopenia, Tooth Abscess, Tooth Repair
Adverse event was reported on Aug 11, 2010 by a Male patient taking Pegasys (View Usage) (Dosage: ) was diagnosed with hepatitis c (What is hepatitis c?), depression (What is depression?) and. Location: UNITED STATES , weighting 128.1 lb, Patient had the following side effects: diabetic ketoacidosis, hypocalcaemia, hypophosphataemia, impaired healing, pancreatitis acute, surgery (What is surgery?), thrombocytopenia, tooth abscess, tooth repair. During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ), PRISTIQ (View Pristiq Review and Pristiq Label ). Patient was hospitalized and became disabled.

6930329-4 | Alkalosis, Diarrhoea, Helicobacter Infection, Hypochloraemia, Hyponatraemia
on Aug 10, 2010 Female patient from GERMANY , weighting 132.3 lb, was treated with Pegasys (View Usage). After Pegasys was administered, patient had the following side effects: alkalosis, diarrhoea, helicobacter infection, hypochloraemia, hyponatraemia. Pegasys dosage: . During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6926207-7 | Chronic Obstructive Pulmonary Disease, Dyspnoea, Ejection Fraction Decreased
on Aug 13, 2010 Male patient from UNITED STATES , 47 years of age, weighting 175.0 lb, was diagnosed with hepatitis c (What is hepatitis c?) and was treated with Pegasys (View Usage). Patient experienced the following unwanted or unexpected effects: chronic obstructive pulmonary disease, dyspnoea, ejection fraction decreased. Pegasys dosage: 1x Per Week Sq. During the same period patient was treated with COPEGUS (View Copegus Review and Copegus Label ).

6925506-2 | Pneumonia, Tracheal Operation
Patient was taking Pegasys (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?), tracheal operation on Aug 10, 2010 from UNITED STATES Additional patient health information: Female patient , 39 years of age, . Pegasys dosage: Received Two Doses. Patient was hospitalized.